Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.7 |
mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |